Moolec Science (MLEC) Amortizatization of Intangibles (2023 - 2024)
Moolec Science's (MLEC) quarterly Amortizatization of Intangibles came in at $7040.0 in Q4 2024, down 80.59% year-on-year from $36273.0 in Q1 2024, and down 81.82% quarter-over-quarter from $38732.0 in Q3 2024.
Moolec Science (MLEC) Amortizatization of Intangibles (2023 - 2024) Analysis & Trends
Moolec Science has disclosed Amortizatization of Intangibles across 2 years of filings, most recently posting $7040.0 for Q4 2024.
- Amortizatization of Intangibles for Q4 2024 came in at $7040.0, down 80.59% year-over-year; the trailing twelve-month figure through Dec 2024 was $12.1 million (changed N/A YoY), and the FY2025 annual result was $11.2 million, down 7.53% from the prior year.
- Amortizatization of Intangibles came in at $7040.0 for Q4 2024 at Moolec Science, down from $38732.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $11.6 million in Q2 2024 to a low of $7040.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7,040.00 |
| Dec 31, 2024 | 7,040.00 |
| Sep 30, 2024 | 38,732.00 |
| Sep 30, 2024 | 38,732.00 |
| Jun 30, 2024 | 11.59 Mn |
| Jun 30, 2024 | 11.59 Mn |
| Mar 31, 2024 | 479,022.00 |
| Mar 31, 2024 | 479,022.00 |
| Dec 31, 2023 | 36,273.00 |
| Dec 31, 2023 | 36,273.00 |
| Sep 30, 2023 | 9,894.00 |
| Sep 30, 2023 | 9,894.00 |